CinRx Pharma’s most prominent spinout is CinCor Pharma, which was acquired by AstraZeneca last year. The startup creator will apply its new capital toward current programs and to expand to additional areas of unmet medical need.

The post CinRx Pharma Corrals $73M to Continue ‘Hub and Spoke’ Model of Startup Formation appeared first on MedCity News.

The NIH’s SEED office formed to help startups leverage government’s funding programs. Chris Sasiela, director of the SEED office, discussed these programs during the MedCity News INVEST Conference in Chicago.

The post 5 Things to Know About How NIH’s SEED Can Help Life Science Startups Grow appeared first on MedCity News.

Blackstone Life Sciences startup Uniquity Bio emerged from stealth with an in-licensed drug candidate that could treat a wide range of immunology and inflammation indications. The antibody’s target puts it in competition with drugs from AstraZeneca, Pfizer, and Sanofi.

The post Blackstone Unveils Immunology Startup With $300M and a Phase 2-Ready Drug From Merck appeared first on MedCity News.

AbbVie’s alliance with Gilgamesh Pharmaceuticals is pursuing next-generation psychiatric medications. The companies aim to bring patients drugs that offer the benefit of psychedelics but with a better side effect profile.

The post AbbVie Expands Psychiatric Drug Prospects, Inking R&D Pact With Neuroscience Startup appeared first on MedCity News.

The boutique healthcare investment conference in Chicago is scheduled for May 21-22. Space is limited so register today!

The post Healthcare Investment Trends Take Center Stage at MedCity INVEST appeared first on MedCity News.

Eli Lilly-partnered Lycia Therapeutics will use its Series C financing to continue developing its internal pipeline of protein-degrading drugs. The startup is working to reach the clinic with drugs for autoimmune and inflammatory disorders.

The post Lycia Therapeutics Lands $106M for Protein Degraders That Treat Autoimmune & Inflammatory Diseases appeared first on MedCity News.

Check out news from Alpha Sophia, Triomics, In-House Health, and Humanaut Health.

The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.

The conference is the premier boutique healthcare investment event in the U.S. and is scheduled for May 21-22 in Chicago at the Ritz Carlton hotel.

The post There’s Still Time to Register for MedCity INVEST appeared first on MedCity News.

Enlaza Therapeutics’ drugs form covalent bonds that lock the therapy onto its target. With cancer as its initial focus, the startup contends its approach could offer safety and efficacy advantages compared to currently available targeted therapies.

The post J.P. Morgan Leads $100M Financing for Startup’s R&D of Covalent Biologic Drugs for Cancer appeared first on MedCity News.

Check out news from Alpha Sophia, Handl Health, Alaffia Health, and Summer Health

The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.

Two Japanese pharmaceutical companies and a bank are teaming up to form a joint venture to advance therapeutic discoveries from academia. The focus will be innovation from universities in Japan.

The post Takeda, Astellas & Sumitomo Mitsui Form Joint Venture to Lift Japanese Innovation From ‘Valley of Death’ appeared first on MedCity News.

In addition to panel discussions around some of the hottest topics in healthcare transformation, there is also a startup pitch contest, a presentation on government funding for startups and networking opportunities.

The post Want to Connect with Innovative Healthcare Startups and Investors? Register for MedCity INVEST Today! appeared first on MedCity News.

These health tech companies focused on the consumer and self-insured employer market will take part in the MedCity INVEST Pitch Perfect contest May 21-22 in Chicago. Register today!

The post 6 Women’s Health Startups You Should Get to Know appeared first on MedCity News.

Seaport Therapeutics’ drug candidates are delivered through the lymphatic system, an approach that could overcome some limitations of neuropsychiatric medicines, including products from Sage Therapeutics. The startup stems from the research of PureTech Health.

The post PureTech Startup Gets $100M to Try For Success Where Sage & Others Fall Short in Depression appeared first on MedCity News.

Diagonal Therapeutics develops agonist antibodies to treat rare cardiovascular conditions. Using artificial intelligence, the startup’s technology sorts through billions of antibody/receptor combinations to identify the ones that reactivate signaling pathways lost to disease.

The post Diagonal Therapeutics’ New Slant Attracts $128M to Reactivate Antibody Drug R&D appeared first on MedCity News.

Mirador Therapeutics applies machine learning to human data to discover new immunology and inflammation drugs. The startup’s management includes several from the executive team of Prometheus Biosciences, an immunology biotech bought by Merck last year.

The post Precision Medicine Startup Mirador Unveils $400M for R&D of New I&I Drugs appeared first on MedCity News.

Clasp Therapeutics’ novel T cell engagers could offer advantages over others in this class of cancer immunotherapies. The startup is based on the research of Johns Hopkins University scientist Bert Vogelstein.

The post Startup Lands $150M for Delicate Dance Between Cancer Cells & Immune Cells appeared first on MedCity News.

At the MedCity INVEST conference, scheduled for May 21-22 at the Ritz Carlton in Chicago, health benefits in the context of value-based care will be one of several topics of discussion at the boutique healthcare investment event. Register today!

The post In the Era of Value-Based Care, How Are Employer-Provided Health Benefits Evolving? appeared first on MedCity News.

Tubulis’s next-generation ADC cancer drugs are designed to overcome limitations of currently available therapies in this drug class. The new financing will support clinical trial plans, but first, preclinical proof-of-concept data will be presented during the American Association for Cancer Research annual meeting.

The post A Startup’s Flexibility With ADC Cancer Drugs Attracts €128M for Clinical Trials appeared first on MedCity News.

Check out news from Band Connect, Fijoya, Team8, and BrainCheck.

The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.

The premier boutique healthcare investment conference is scheduled for May 21-22 at the Ritz Carlton hotel in Chicago

The post Come to MedCity INVEST, Where You Could Meet Your Startup’s First Institutional Investor or a Future Portfolio Company! appeared first on MedCity News.

Check out news from Alpha Sophia, Abridge, Baseimmune, Carewell, and Redi Health.

The post StartUPDATES: New developments from healthcare startups appeared first on MedCity News.

Orbis Medicines is developing macrocyclic peptides that address a wider range of targets and can be taken as oral pills. Novo Holdings and Forbion are backing the startup, which is based on research from the scientific co-founder of peptide drug developer Bicycle Therapeutics.

The post Startup Orbis Medicines Launches With €26M for Next-Generation Peptide Drugs appeared first on MedCity News.

Regenerative medicine startup Pelage Pharmaceuticals has clinical data showing its small molecule activated hair follicle stem cells. GV led a Series A round that funded the UCLA spinout’s Phase 1 clinical trial and will also support Phase 2 testing this year.

The post Roots Start to Show for Hair Loss Startup Pelage With a Peek at First Clinical Data appeared first on MedCity News.

In preclinical testing, combining BioAge Labs’ experimental drug with Eli Lilly weight drug Zepbound led to greater weight loss compared with Zepbound alone. Now the company plans to run a Phase 2 study to see if it can replicate those results in humans.

The post Lose Fat, Not Muscle: Next Test for Lilly’s Zepbound Pairs It With BioAge Drug appeared first on MedCity News.

The conference, scheduled for May 21-22 at the Ritz Carlton hotel in Chicago, brings together healthcare investors, startups, and innovative-minded executives. Register today!

The post Network With Healthcare Investors at MedCity INVEST 2024! appeared first on MedCity News.

Are you a biopharma startup focused on oncology? A devices /diagnostics startup focused on cardiology? Or a health tech startup focused on how consumers/employers
are addressing women’s health? If so, submit an application for MedCity INVEST Pitch Perfect by February 29!

The post Healthcare Startups, Time is Running Out to Enter the MedCity INVEST Pitch Perfect Contest in Chicago appeared first on MedCity News.

The conference, scheduled for May 21-22 at the Ritz Carlton in Chicago, is the premier boutique healthcare investment event in the U.S.

The post Register for MedCity INVEST in Chicago Where Investors and Healthcare Startups Connect appeared first on MedCity News.

Equal parts networking and curated panels covering the latest trends in healthcare investment, MedCity INVEST 2024 is the ideal event to discuss health tech, biopharma, devices and diagnostics investment opportunities. Register today!

The post Connect With More Than 50 Healthcare Startups at MedCity INVEST 2024! appeared first on MedCity News.

Versant Ventures-backed Firefly Bio is part of a growing group of companies developing degrader antibody conjugates, or DACs. These targeted cancer therapies combine properties of antibody drug conjugates and protein degraders in order to overcome limitations of both types of therapies.

The post Firefly Bio Unveils $94M to Illuminate the Startup’s New Take on ADC Cancer Meds appeared first on MedCity News.